# SPIRONOLACTONE
> **ANDA218085** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2025-02-21
## Drug
- **FDA Application Number:** ANDA218085
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SPIRONOLACTONE
- **Generic name:** SPIRONOLACTONE
- **Active ingredients:** SPIRONOLACTONE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HETERO LABS LTD III
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2025-02-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218085)
---
*MORVS · CC0 1.0*